2023 Annual Report
We're pleased to share with you our latest Annual Report, which highlights everything we accomplished in 2023.
We're pleased to share with you our latest Annual Report, which highlights everything we accomplished in 2023.
TAG's emergency plea to our allies at MSF to preserve its life-saving and world-changing MSF Access Campaign (Campaign for Access to Essential Medicines) — we need them now more than ever!
Treatment Action Group (TAG) welcomes the news that the long-acting injectable HIV capsid inhibitor lenacapavir has proven efficacious at preventing HIV acquisition among young women and adolescent girls in South Africa and Uganda.
Microarray patches (MAPs) are arrays of microneedles that stick to your skin like a bandage, offering a noninvasive mechanism for drug administration.
TAG delivered an intervention at the UN High-Level Meeting on Antimicrobial Resistance (AMR) Multistakeholder Hearing, calling on member states to incorporate drug-resistant TB (DR-TB) in the political declaration as a key component of AMR response.
On May 15, 2024, TAG hosted this webinar on the TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing.
Rifapentine, an off-patent drug that's been around since the 1960s, is the cornerstone of the two most effective regimens to prevent tuberculosis (TB) in people at risk of the disease.
TAG hosted this May 31 webinar on the growing pipeline of microarray patches (MAPs) for various infectious diseases treatment and immunization.
Follow along with one of our staff members on a typical day, and you'll see the difference you make as a TAG donor and partner.
1997 Michael Palm* Dr. David Ho 1998 Wafaa El-Sadr Dr. Mathilde Krim* 1999 Dr. Harold Varmus Irene Diamond* Spencer Cox* 2000 Tom Viola, BC/EFA Dr. Anthony S. Fauci Lynda M. Dee, Esq. 2001 Gregg Gonsalves Michael Cunningham Dr. Art Ammann*…